New findings could improve treatment options for people with hard-to-treat infections. An antibiotic-resistant bacterium (Escherichia coli) is treated with an antibiotic (colistin) and a DsbA ...

Cystic fibrosis is a genetic disease that causes serious and sometimes fatal respiratory and digestive disorders. A new treatment, available since 2020, improves lung function and quality of life.

A newly discovered mechanism renders antibiotic-resistant bacteria vulnerable by disabling both their individual resistance and a process known as cross-protection, the ability of resistant bacteria ...

University of Queensland researchers have identified an opportunity to reduce infections in people living with cystic fibrosis (CF). Professor Matt Sweet, Dr. Kaustav Das Gupta and Dr. James Curson ...

Please provide your email address to receive an email when new articles are posted on . Elexacaftor/tezacaftor/ivacaftor is an approved treatment for children and ...

Please provide your email address to receive an email when new articles are posted on . Patients with cystic fibrosis may be more susceptible to infections due to a defect in their immune cells.

As a 40-year-old who lives with cystic fibrosis (CF), Zachary Schulz, PhD, EdS, MPH, is said to be among the reputed “last generation” of patients — those born before the advent of drugs that target ...

Scientists have made new headway in understanding how a deadly pathogen evolves during chronic lung infections in cystic fibrosis patients. Cystic fibrosis (CF) is the most common fatal genetic ...

Interim findings showed patients (n=21) treated with CMTX-101 saw a reduction in Pseudomonas aeruginosa burden. The Food and Drug Administration (FDA) has granted Fast Track and Qualified Infectious ...

A newly discovered mechanism renders antibiotic-resistant bacteria vulnerable by disabling both their individual resistance and a process known as cross-protection, the ability of resistant bacteria ...

The anchor points present on the surface of the airways in cystic fibrosis (left, in red) decrease when the balance between the two cell signalling pathways is restored (right). Cystic fibrosis is a ...